×
Grifols, S.A - 14 Year Stock Split History | GRFS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Stock Price History
Stock Splits
Market Cap
The most recent stock split for Grifols, S.A (GRFS) was a
2:1 split
on January 4, 2016. The combined total of all historical stock splits for Grifols, S.A result in
2.42 current shares
for every original share available at the IPO in 2011.
View More
Grifols, S.A - 14 Year Stock Split History | GRFS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Stock Price History
Stock Splits
Market Cap
Related Stocks
Company Name
Market
Cap
Zoetis (ZTS)
$74.8B
Chugai Pharmaceutical (CHGCY)
$70.2B
Takeda Pharmaceutical (TAK)
$41.1B
Sandoz Group AG (SDZNY)
$19.6B
Merck (MKKGY)
$18.8B
Astellas Pharma (ALPMY)
$17.3B
United Therapeutics (UTHR)
$16B
Neurocrine Biosciences (NBIX)
$14.5B
Summit Therapeutics (SMMT)
$14B
Shionogi (SGIOY)
$12.1B
Orion OYJ (ORINY)
$7.2B
Stevanato Group S.p.A (STVN)
$6.9B
Madrigal Pharmaceuticals (MDGL)
$6.4B
Corcept Therapeutics (CORT)
$5.8B
Hikma Pharmaceuticals Plc (HKMPF)
$5.5B
Ionis Pharmaceuticals (IONS)
$5B
Crinetics Pharmaceuticals (CRNX)
$3.5B
Catalyst Pharmaceuticals (CPRX)
$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.6B
Recursion Pharmaceuticals (RXRX)
$2.6B
NewAmsterdam Pharma (NAMS)
$2.2B
Soleno Therapeutics (SLNO)
$2B
Centessa Pharmaceuticals (CNTA)
$2B
Hypermarcas (HYPMY)
$1.9B
Indivior (INDV)
$1.6B
BioCryst Pharmaceuticals (BCRX)
$1.5B
Evotec AG (EVO)
$1.5B
Dyne Therapeutics (DYN)
$1.4B
Xencor (XNCR)
$1.3B
Guardian Pharmacy Services (GRDN)
$1.3B